SC PIL seeks 3-month probe, one-year trial in fake drug cases
A Supreme Court PIL by advocate Ashwini Upadhyay seeks 3-month probes, 1-year trials and property confiscation to curb India's fake medicine racket.
Simple explainers on world affairs, science, health and more.
All news under one minute
A Supreme Court PIL by advocate Ashwini Upadhyay seeks 3-month probes, 1-year trials and property confiscation to curb India's fake medicine racket.
The Supreme Court reserved judgment on mandatory front-of-pack warning labels for packaged foods high in sugar, salt and fat, saying its order…
Labour Minister Mansukh Mandaviya said ESIC health cover now reaches 25 crore people, while free food grains go to 80 crore and…
FDA approved Moderna's mFlusiva, the first mRNA flu vaccine, for adults 50+. But the CDC has not recommended it, citing legal uncertainties…
CDC's 2026 Annual Report to the Nation finds US cancer death rates fell 2019-2023, with lung cancer mortality down 4.7% per year…
CDC and FDA are investigating an E. coli O26 outbreak tied to Graziers raw-milk cheese in 9 states: 13 cases, eight hospitalized,…
A Blue Cross Blue Shield study found AI-assisted coding added nearly $1 billion in extra costs for member insurers over two years…
Pope Leo XIV condemned the legalization of medically assisted death as false compassion, reaffirming Catholic teaching on the sanctity of life at…
India's drug regulator has inspected 49 entities over unauthorized sales of generic weight-loss jabs, warning of licence cancellations and prosecution.
Dr Reddy's and Takeda signed a deal to bring Qdenga, India's first approved dengue vaccine, to the private market in the first…